Victor T T Chan1, Zihan Sun2, Shumin Tang2, Li Jia Chen2, Adrian Wong3, Clement C Tham2, Tien Y Wong4, Christopher Chen5, M Kamran Ikram6, Heather E Whitson7, Eleonora M Lad8, Vincent C T Mok9, Carol Y Cheung10. 1. Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China. 2. Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China. 3. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China. 4. Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Republic of Singapore; Duke-NUS Medical School, National University of Singapore, Singapore, Republic of Singapore. 5. Memory Aging and Cognition Centre, National University Health System, Singapore, Republic of Singapore; Department of Pharmacology, National University of Singapore, Singapore, Republic of Singapore. 6. Departments of Neurology and Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands. 7. Duke University Medical Center, Durham, North Carolina; Geriatrics Research Education and Clinical Center (GRECC), Durham VA Medical Center, Durham, North Carolina. 8. Duke University Medical Center, Durham, North Carolina. 9. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; Therese Pei Fong Chow Research Centre for Prevention of Dementia, The Chinese University of Hong Kong, Hong Kong, China. 10. Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China. Electronic address: carolcheung@cuhk.edu.hk.
Abstract
TOPIC: OCT is a noninvasive tool to measure specific retinal layers in the eye. The relationship of retinal spectral-domain (SD) OCT measurements with Alzheimer's disease (AD) and mild cognitive impairment (MCI) remains unclear. Hence, we conducted a systematic review and meta-analysis to examine the SD OCT measurements in AD and MCI. CLINICAL RELEVANCE: Current methods of diagnosing early AD are expensive and invasive. Retinal measurements of SD OCT, which are noninvasive, technically simple, and inexpensive, are potential biomarkers of AD. METHODS: We conducted a literature search in PubMed and Excerpta Medica Database to identify studies published before December 31, 2017, that assessed the associations between AD, MCI, and measurements of SD OCT: ganglion cell-inner plexiform layer (GC-IPL), ganglion cell complex (GCC), macular volume, and choroidal thickness, in addition to retinal nerve fiber layer (RNFL) and macular thickness. We used a random-effects model to examine these relationships. We also conducted meta-regression and assessed heterogeneity, publication bias, and study quality. RESULTS: We identified 30 eligible studies, involving 1257 AD patients, 305 MCI patients, and 1460 controls, all of which were cross-sectional studies. In terms of the macular structure, AD patients showed significant differences in GC-IPL thickness (standardized mean difference [SMD], -0.46; 95% confidence interval [CI], -0.80 to -0.11; I2 = 71%), GCC thickness (SMD, -0.84; 95% CI, -1.10 to -0.57; I2 = 0%), macular volume (SMD, -0.58; 95% CI, -1.03 to -0.14; I2 = 80%), and macular thickness of all inner and outer sectors (SMD range, -0.52 to -0.74; all P < 0.001) when compared with controls. Peripapillary RNFL thickness (SMD, -0.67; 95% CI, -0.95 to -0.38; I2 = 89%) and choroidal thickness (SMD range, -0.88 to -1.03; all P < 0.001) also were thinner in AD patients. CONCLUSIONS: Our results confirmed the associations between retinal measurements of SD OCT and AD, highlighting the potential usefulness of SD OCT measurements as biomarkers of AD.
TOPIC: OCT is a noninvasive tool to measure specific retinal layers in the eye. The relationship of retinal spectral-domain (SD) OCT measurements with Alzheimer's disease (AD) and mild cognitive impairment (MCI) remains unclear. Hence, we conducted a systematic review and meta-analysis to examine the SD OCT measurements in AD and MCI. CLINICAL RELEVANCE: Current methods of diagnosing early AD are expensive and invasive. Retinal measurements of SD OCT, which are noninvasive, technically simple, and inexpensive, are potential biomarkers of AD. METHODS: We conducted a literature search in PubMed and Excerpta Medica Database to identify studies published before December 31, 2017, that assessed the associations between AD, MCI, and measurements of SD OCT: ganglion cell-inner plexiform layer (GC-IPL), ganglion cell complex (GCC), macular volume, and choroidal thickness, in addition to retinal nerve fiber layer (RNFL) and macular thickness. We used a random-effects model to examine these relationships. We also conducted meta-regression and assessed heterogeneity, publication bias, and study quality. RESULTS: We identified 30 eligible studies, involving 1257 ADpatients, 305 MCI patients, and 1460 controls, all of which were cross-sectional studies. In terms of the macular structure, ADpatients showed significant differences in GC-IPL thickness (standardized mean difference [SMD], -0.46; 95% confidence interval [CI], -0.80 to -0.11; I2 = 71%), GCC thickness (SMD, -0.84; 95% CI, -1.10 to -0.57; I2 = 0%), macular volume (SMD, -0.58; 95% CI, -1.03 to -0.14; I2 = 80%), and macular thickness of all inner and outer sectors (SMD range, -0.52 to -0.74; all P < 0.001) when compared with controls. Peripapillary RNFL thickness (SMD, -0.67; 95% CI, -0.95 to -0.38; I2 = 89%) and choroidal thickness (SMD range, -0.88 to -1.03; all P < 0.001) also were thinner in ADpatients. CONCLUSIONS: Our results confirmed the associations between retinal measurements of SD OCT and AD, highlighting the potential usefulness of SD OCT measurements as biomarkers of AD.
Authors: Kaj Blennow; Niklas Mattsson; Michael Schöll; Oskar Hansson; Henrik Zetterberg Journal: Trends Pharmacol Sci Date: 2015-04-01 Impact factor: 14.819
Authors: Christopher K S Leung; Marco Yu; Robert N Weinreb; Cong Ye; Shu Liu; Gilda Lai; Dennis S C Lam Journal: Ophthalmology Date: 2012-01-20 Impact factor: 12.079
Authors: G Vizzeri; R N Weinreb; A O Gonzalez-Garcia; C Bowd; F A Medeiros; P A Sample; L M Zangwill Journal: Br J Ophthalmol Date: 2009-03-19 Impact factor: 4.638
Authors: Pete A Williams; Rebecca A Thirgood; Huw Oliphant; Aura Frizzati; Elinor Littlewood; Marcela Votruba; Mark A Good; Julie Williams; James E Morgan Journal: Neurobiol Aging Date: 2013-03-07 Impact factor: 4.673
Authors: Michael A Williams; Amy J McGowan; Chris R Cardwell; Carol Y Cheung; David Craig; Peter Passmore; Giuliana Silvestri; Alexander P Maxwell; Gareth J McKay Journal: Alzheimers Dement (Amst) Date: 2015-05-16
Authors: Stephen P Yoon; Dilraj S Grewal; Atalie C Thompson; Bryce W Polascik; Cynthia Dunn; James R Burke; Sharon Fekrat Journal: Ophthalmol Retina Date: 2019-03-11
Authors: Natascha Merten; Adam J Paulsen; A Alex Pinto; Yanjun Chen; Lauren K Dillard; Mary E Fischer; Guan-Hua Huang; Barbara E K Klein; Carla R Schubert; Karen J Cruickshanks Journal: J Gerontol A Biol Sci Med Sci Date: 2020-09-16 Impact factor: 6.053
Authors: Sophia Ling Li; Ka Wai Kam; Arnold Shau Hei Chee; Xiu Juan Zhang; Li Jia Chen; Wilson W K Yip; Clement C Tham; Alvin L Young; Ian C K Wong; Patrick Ip; Jason C Yam Journal: Int Ophthalmol Date: 2021-05-20 Impact factor: 2.031
Authors: Deepthi Bannai; Paulo Lizano; Megan Kasetty; Olivia Lutz; Victor Zeng; Suraj Sarvode; Leo A Kim; Scot Hill; Carol Tamminga; Brett Clementz; Elliot Gershon; Godfrey Pearlson; John B Miller; Matcheri Keshavan Journal: Psychiatry Res Neuroimaging Date: 2020-02-29 Impact factor: 2.376
Authors: Marta Para-Prieto; Raul Martin; Sara Crespo; Laura Mena-Garcia; Andres Valisena; Lisandro Cordero; Gloria Gonzalez Fernandez; Juan F Arenillas; Nieves Tellez; Jose Carlos Pastor Journal: Clin Ophthalmol Date: 2021-05-14
Authors: Peter J Snyder; Jessica Alber; Clemens Alt; Lisa J Bain; Brett E Bouma; Femke H Bouwman; Delia Cabrera DeBuc; Melanie C W Campbell; Maria C Carrillo; Emily Y Chew; M Francesca Cordeiro; Michael R Dueñas; Brian M Fernández; Maya Koronyo-Hamaoui; Chiara La Morgia; Roxana O' Carare; Srinivas R Sadda; Peter van Wijngaarden; Heather M Snyder Journal: Alzheimers Dement Date: 2020-10-08 Impact factor: 21.566
Authors: Axel Petzold; Philipp Albrecht; Laura Balcer; Erik Bekkers; Alexander U Brandt; Peter A Calabresi; Orla Galvin Deborah; Jennifer S Graves; Ari Green; Pearse A Keane; Jenny A Nij Bijvank; Josemir W Sander; Friedemann Paul; Shiv Saidha; Pablo Villoslada; Siegfried K Wagner; E Ann Yeh Journal: Ann Clin Transl Neurol Date: 2021-05-19 Impact factor: 4.511